Are there women who should not take raloxifene?
Raloxifene is not FDA-approved for use in premenopausal women for any indication. It is approved for the prevention and treatment of osteoporosis as well as for the reduction of breast cancer risk in postmenopausal women. Postmenopausal women with a history of blood clots, hypertension, diabetes and cigarette smoking must also consider that raloxifene increases the risk of serious blood clots.
